SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000882104-18-000051
Filing Date
2018-06-12
Accepted
2018-06-12 16:12:26
Documents
2
Period of Report
2018-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_152883432750412.html 3  
1 FORM 3 wf-form3_152883432750412.xml 3 1730
2 POWER OF ATTORNEY: /S/ NATHAN N. KRYSZAK, ATTORNEY-IN-FACT FOR JILL JENE ex-24.htm EX-24 3649
  Complete submission text file 0000882104-18-000051.txt   6822
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
Jene Jill M. (Reporting) CIK: 0001742105 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19756 | Film No.: 18894569